ER Reactivation Therapy for Breast Cancer (POLLY)
In this study, patients will alternate anti-cancer drugs without waiting for the cancer to get worse. We want to see if alternating medicines will lengthen the time it takes for the cancer to get worse, and to prevent the cancer from getting worse.
This research study is led by Dr. Grace Makari-Judson.
Contact: Katie Colbeck, 413-794-9875
March 11, 2016
Cancer - Breast,
D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA
ER+/HER2-, Metastatic Breast Cancer
Interventional (Clinical Trial)